The anemia of some malignancies, including Hodgkin’s disease, multiple myeloma, and myelofibrosis (54–56), resembles anemia of inflammation and is accompanied by increased hepcidin production stimulated by inflammatory cytokines. Here, HAMP is linked to plasma cell myeloma.